Kanayama N et al. |
Drug-drug interactions in the metabolism of imidafenacin: role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes. |
2007 |
Xenobiotica |
pmid:17484517
|
Altintas E et al. |
Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. |
2004 |
World J. Gastroenterol. |
pmid:15162544
|
Cindoruk M et al. |
Influence of H pylori on plasma ghrelin in patients without atrophic gastritis. |
2007 |
World J. Gastroenterol. |
pmid:17461454
|
Mesquita MA et al. |
One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer. |
2005 |
World J. Gastroenterol. |
pmid:15962376
|
Cosme A et al. |
Antimicrobial susceptibility testing before first-line treatment for infection in patients with dual or triple antibiotic resistance. |
2017 |
World J. Gastroenterol. |
pmid:28566898
|
Keshavarz AA et al. |
Omeprazole-based triple therapy with low-versus high-dose of clarithromycin plus amoxicillin for H pylori eradication in Iranian population. |
2007 |
World J. Gastroenterol. |
pmid:17352026
|
Lai YC et al. |
Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers. |
2003 |
World J. Gastroenterol. |
pmid:12854158
|
Losurdo G et al. |
Role of concomitant therapy for eradication: A technical note. |
2016 |
World J. Gastroenterol. |
pmid:27784977
|
Choi HS et al. |
Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection. |
2012 |
World J. Gastroenterol. |
pmid:22654429
|
Si JM et al. |
Quality of gastric ulcer healing evaluated by endoscopic ultrasonography. |
2005 |
World J. Gastroenterol. |
pmid:15948255
|
Hagiwara T et al. |
Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of H pylori infection. |
2007 |
World J. Gastroenterol. |
pmid:17657838
|
Kawakami E et al. |
Furazolidone-based triple therapy for H pylori gastritis in children. |
2006 |
World J. Gastroenterol. |
pmid:17006997
|
Sanches BS et al. |
Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey. |
2016 |
World J. Gastroenterol. |
pmid:27672279
|
Huang JQ et al. |
Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review. |
2005 |
World J. Gastroenterol. |
pmid:15884111
|
Robles-Jara C et al. |
Is a 7-day Helicobater pylori treatment enough for eradication and inactivation of gastric inflammatory activity? |
2008 |
World J. Gastroenterol. |
pmid:18473407
|
Koussoulas V et al. |
Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease. |
2007 |
World J. Gastroenterol. |
pmid:17729416
|
Hwang JJ et al. |
Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease. |
2015 |
World J. Gastroenterol. |
pmid:25945019
|
Gumurdulu Y et al. |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. |
2004 |
World J. Gastroenterol. |
pmid:14991935
|
Ahmad N et al. |
Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori. |
2009 |
World J. Gastroenterol. |
pmid:19575497
|
Guo CY et al. |
Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection. |
2004 |
World J. Gastroenterol. |
pmid:14991953
|
Mirbagheri SA et al. |
Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial. |
2006 |
World J. Gastroenterol. |
pmid:16937475
|
Luo XF et al. |
Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori. |
2016 |
World J. Gastroenterol. |
pmid:27433095
|
Attaran B et al. |
Effect of biofilm formation by clinical isolates of on the efflux-mediated resistance to commonly used antibiotics. |
2017 |
World J. Gastroenterol. |
pmid:28275296
|
Lin LC et al. |
Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials. |
2016 |
World J. Gastroenterol. |
pmid:27340362
|
Ching SS et al. |
Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital. |
2008 |
World J. Gastroenterol. |
pmid:18609709
|
Miehlke S et al. |
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). |
2001 |
World J. Gastroenterol. |
pmid:11819768
|
Trifan A et al. |
Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication. |
2013 |
World J. Gastroenterol. |
pmid:24259981
|
Iannone A et al. |
New fecal test for non-invasive detection: A diagnostic accuracy study. |
2018 |
World J. Gastroenterol. |
pmid:30038469
|
Sun QJ et al. |
Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai. |
2010 |
World J. Gastroenterol. |
pmid:20976850
|
Bustamante-Rengifo JA et al. |
In vitro effect of amoxicillin and clarithromycin on the 3' region of cagA gene in Helicobacter pylori isolates. |
2013 |
World J. Gastroenterol. |
pmid:24106405
|
Lan L et al. |
Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia. |
2011 |
World J. Gastroenterol. |
pmid:21912474
|
Gisbert JP |
"Rescue" regimens after Helicobacter pylori treatment failure. |
2008 |
World J. Gastroenterol. |
pmid:18803350
|
Chuah SK et al. |
A new look at anti-Helicobacter pylori therapy. |
2011 |
World J. Gastroenterol. |
pmid:22046084
|
Matta AJ et al. |
Punctual mutations in gene of clarithromycin-resistant in Colombian populations. |
2018 |
World J. Gastroenterol. |
pmid:29662291
|
Lee HJ et al. |
Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies. |
2015 |
World J. Gastroenterol. |
pmid:25574111
|
Deng ZH et al. |
Influence of Helicobacter pylori infection on ghrelin levels in children. |
2012 |
World J. Gastroenterol. |
pmid:23049220
|
Brennan DE et al. |
Can bacterial virulence factors predict antibiotic resistant infection? |
2018 |
World J. Gastroenterol. |
pmid:29531461
|
Mamori S et al. |
Age-dependent eradication of Helicobacter pylori in Japanese patients. |
2010 |
World J. Gastroenterol. |
pmid:20806435
|
Yoon JH et al. |
Trends in the eradication rates of Helicobacter pylori infection for eleven years. |
2012 |
World J. Gastroenterol. |
pmid:23236238
|
Buzás GM and Józan J |
First-line eradication of H pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2004. |
2006 |
World J. Gastroenterol. |
pmid:16981260
|
Babic Z et al. |
Increased activity of Pgp multidrug transporter in patients with Helicobacter pylori infection. |
2005 |
World J. Gastroenterol. |
pmid:15884110
|
Chen SJ et al. |
Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients. |
2008 |
World J. Gastroenterol. |
pmid:18350632
|
Wang B et al. |
Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis. |
2014 |
World J. Gastroenterol. |
pmid:25356059
|
Campuzano-Maya G |
Cure of alopecia areata after eradication of Helicobacter pylori: a new association? |
2011 |
World J. Gastroenterol. |
pmid:21912461
|
Hao Q et al. |
New mutation points in 23S rRNA gene associated with Helicobacter pylori resistance to clarithromycin in northeast China. |
2004 |
World J. Gastroenterol. |
pmid:15052698
|
Sargýn M et al. |
Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori. |
2003 |
World J. Gastroenterol. |
pmid:12717872
|
Abadi ATB |
Resistance to clarithromycin and gastroenterologist's persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization. |
2017 |
World J. Gastroenterol. |
pmid:29085187
|
Lai YC et al. |
Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers. |
2004 |
World J. Gastroenterol. |
pmid:15052680
|
Ji F et al. |
Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. |
2006 |
World J. Gastroenterol. |
pmid:16586550
|
Khan A et al. |
Antibiotic resistance and cagA gene correlation: a looming crisis of Helicobacter pylori. |
2012 |
World J. Gastroenterol. |
pmid:22611319
|
Molina-Infante J and Gisbert JP |
Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance. |
2014 |
World J. Gastroenterol. |
pmid:25132750
|
Cianci R et al. |
Third-line rescue therapy for Helicobacter pylori infection. |
2006 |
World J. Gastroenterol. |
pmid:16688818
|
Zhang L et al. |
Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy. |
2006 |
World J. Gastroenterol. |
pmid:16804982
|
Chang CC et al. |
Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori -induced gastric mucosal damage in Mongolian gerbils. |
2005 |
World J. Gastroenterol. |
pmid:15742400
|
Feng LY et al. |
Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial. |
2005 |
World J. Gastroenterol. |
pmid:15742421
|
Zhou Q et al. |
Drug utilization of clarithromycin for gastrointestinal disease treatment. |
2008 |
World J. Gastroenterol. |
pmid:18932287
|
Sereni G et al. |
Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection. |
2012 |
World J. Gastroenterol. |
pmid:22969227
|
Isomoto H et al. |
Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin. |
2005 |
World J. Gastroenterol. |
pmid:15786539
|
Wang HH et al. |
One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy. |
2005 |
World J. Gastroenterol. |
pmid:15786549
|
Aydemir S et al. |
Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycin. |
2005 |
World J. Gastroenterol. |
pmid:15682477
|
O'Morain C |
Role of Helicobacter pylori in functional dyspepsia. |
2006 |
World J. Gastroenterol. |
pmid:16718752
|
Shimbo I et al. |
Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy. |
2005 |
World J. Gastroenterol. |
pmid:16437727
|
Wang CH et al. |
Effects of daily telephone-based re-education before taking medicine on Helicobacter pylori eradication: A prospective single-center study from China. |
2015 |
World J. Gastroenterol. |
pmid:26494972
|
Sugimoto M and Furuta T |
Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype. |
2014 |
World J. Gastroenterol. |
pmid:24914361
|
Heo J and Jeon SW |
Optimal treatment strategy for Helicobacter pylori: era of antibiotic resistance. |
2014 |
World J. Gastroenterol. |
pmid:24914324
|
Sun WH et al. |
Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients. |
2005 |
World J. Gastroenterol. |
pmid:15832421
|
Wu IT et al. |
Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan. |
2015 |
World J. Gastroenterol. |
pmid:26457027
|
Bustamante-Rengifo JA et al. |
Effect of treatment failure on the CagA EPIYA motif in strains from Colombian subjects. |
2017 |
World J. Gastroenterol. |
pmid:28373764
|
Yilmaz O and Demiray E |
Clinical role and importance of fluorescence in situ hybridization method in diagnosis of H pylori infection and determination of clarithromycin resistance in H pylori eradication therapy. |
2007 |
World J. Gastroenterol. |
pmid:17278188
|
Chen KY et al. |
Hybrid vs sequential therapy for eradication of Helicobacter pylori in Taiwan: A prospective randomized trial. |
2015 |
World J. Gastroenterol. |
pmid:26420970
|
Hwang JJ et al. |
Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication. |
2015 |
World J. Gastroenterol. |
pmid:26401089
|
Zhao LJ et al. |
Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype. |
2014 |
World J. Gastroenterol. |
pmid:24782630
|
Mohammadi M et al. |
Helicobacter pylori antibiotic resistance in Iran. |
2005 |
World J. Gastroenterol. |
pmid:16273615
|
Nishida T et al. |
Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan. |
2014 |
World J. Gastroenterol. |
pmid:24764674
|
Sakurai K et al. |
Comparative study: Vonoprazan and proton pump inhibitors in eradication therapy. |
2017 |
World J. Gastroenterol. |
pmid:28216974
|
Onyekwere CA et al. |
Rabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: report of an efficacy study. |
2014 |
World J. Gastroenterol. |
pmid:24707145
|
Wu JY et al. |
Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests. |
2014 |
World J. Gastroenterol. |
pmid:24695835
|
Gao XZ et al. |
Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication. |
2010 |
World J. Gastroenterol. |
pmid:20818821
|
Mabe K et al. |
Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer? |
2009 |
World J. Gastroenterol. |
pmid:19750572
|
Garza-González E et al. |
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. |
2014 |
World J. Gastroenterol. |
pmid:24587620
|
Farshad S et al. |
Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran. |
2010 |
World J. Gastroenterol. |
pmid:21128326
|
Riquelme A et al. |
Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile. |
2007 |
World J. Gastroenterol. |
pmid:17589948
|
Ersoy O et al. |
H pylori infection in patients with Behcet's disease. |
2007 |
World J. Gastroenterol. |
pmid:17589951
|
Grande M et al. |
Helicobacter pylori and gastroesophageal reflux disease. |
2008 |
World J Surg Oncol |
pmid:18601740
|
Cavanna L et al. |
High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature. |
2008 |
World J Surg Oncol |
pmid:18353178
|
Whittemore KR and Cohen M |
Imaging and review of a large pre-auricular pilomatrixoma in a child. |
2012 |
World J Radiol |
pmid:22761984
|
Yanai A et al. |
Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication: A randomized study in Japan. |
2012 |
World J Gastrointest Pharmacol Ther |
pmid:22408744
|
Francesco VD et al. |
Mechanisms of Helicobacter pylori antibiotic resistance: An updated appraisal. |
2011 |
World J Gastrointest Pathophysiol |
pmid:21860834
|
Bago P et al. |
High eradication rate of H. pylori with moxifloxacin-based treatment: a randomized controlled trial. |
2007 |
Wien. Klin. Wochenschr. |
pmid:17634896
|
Bago J et al. |
The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial. |
2002 |
Wien. Klin. Wochenschr. |
pmid:12422579
|
Bago J et al. |
Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection. |
2004 |
Wien. Klin. Wochenschr. |
pmid:15379146
|
Vcev A et al. |
Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial). |
2001 |
Wien. Klin. Wochenschr. |
pmid:11802510
|
Li Y et al. |
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis. |
2010 |
Wien. Klin. Wochenschr. |
pmid:20628905
|
NiziÄ T et al. |
Solitary erythema migrans in children: comparison of treatment with clarithromycin and amoxicillin. |
2012 |
Wien. Klin. Wochenschr. |
pmid:22760494
|
Kurz H and Göpfrich H |
[Epidemiology and morbidity of mycoplasma as causative agent for community-acquired pneumonia in hospitalized children in a Community Hospital in Vienna]. |
2011 |
Wien Med Wochenschr |
pmid:20963506
|
Kardas P and Muras M |
[A blinded comparison of palatability of 13 common pediatric antibiotic suspensions]. |
2005 |
Wiad. Lek. |
pmid:15991547
|
Gościmski A et al. |
[Microflora of gastric juice in patients after eradication of Helicobacter pylori and treatment with a proton pump inhibitor]. |
2002 |
Wiad. Lek. |
pmid:12043311
|
Dhawan VK et al. |
Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients. |
1998 |
West. J. Med. |
pmid:9830355
|
Kanatani MS and Guglielmo BJ |
The new macrolides. Azithromycin and clarithromycin. |
1994 |
West. J. Med. |
pmid:8128699
|
Feng X et al. |
[Interaction between biofilm formed by Pseudomonas aeruginosa and antibacterial agents]. |
2000 |
Wei Sheng Wu Xue Bao |
pmid:12548947
|